Testing

The LSI dual break-apart rearrangement probe contains two differently labelled probes on either sides of the breakpoint of the ROS1 gene. ROS1 has multiple fusion partners including but not limited…
Learn more
The LSI dual break-apart rearragement probe contains two differently labelled probes on either sides of the breakpoint of the ALK gene. ALK has multiple fusion partners including NPM in anaplastic…
Learn more
Translocation (11;18)(q21;q21) has been associated with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). Translocation (11;18) leads to the fusion of the apoptosis inhibitor-2 (API2) gene and…
Learn more
This small, multiprobe panel contributes to the distinction of Burkitt’s from large B-cell lymphoma on problematic specimens demonstrating borderline morphologic or immunophenotypic features, limited sample volume, or zero to low…
Learn more
Her2/neu, also known as erbB2 or HER2, plays a key role in the regulation of cell growth. HER2 is over expressed through gene amplification in 25-30% of breast cancer patients.…
Learn more
Mantle cell lymphoma can be difficult to distinguish morphologically from other B-cell malignant lymphomas. The translocation probe is designed to detect the juxtaposition of the IGH locus (14q32) next to…
Learn more
The FDA recently approved trastuzumab (Herceptin, Genentech) for use in combination with cisplatin and capecitabine or 5-fluorouracil to treat patients with human epidermal growth factor receptor 2 (HER2)-over expressing (also…
Learn more
Translocation (11;18)(q21;q21) has been associated with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). Translocation (11;18) leads to the fusion of the apoptosis inhibitor-2 (API2) gene and…
Learn more
Trisomy 13, trisomy 18 and trisomy 21, and numerical errors of the sex chromosomes (X and Y) constitute the most common chromosome abnormalities observed at prenatal diagnosis. DNA probes specific…
Learn more
The B-cell lymphoma 6 (BCL6) gene is localized to 3q27. Rearrangements of 3q27 may be seen in case diffuse large B-cell lymphoma (30-40%) and follicular lymphoma (5-15%). Structural rearrangements include…
Learn more
The t(8;14)(q32;q24) joins the cellular oncogenes C-MYC with sequences from immunoglobulin heavy chain gene enhancers leading to deregulated expression of C-MYC protein. This abnormality is characteristic of Burkitt lymphoma and…
Learn more
Sequence alterations of the EGFR gene have frequently been identified in non-small cell lung carcinoma (NSCLC), primarily in those patients who were responsive to Gefitinib, an EGFR tyrosine kinase inhibitor.…
Learn more
BCL2 blocks apoptosis and maintains long-term immune responsiveness including B-cell memory. The most frequent non-random chromosome rearrangement in non-Hodgkin lymphoma (NHL) of B-cell type is t(14;18)(q32;q21), which is found in…
Learn more
Broad spectrum cocktail, keratin, epithelial; by IHC
Learn more
WT-1 tumor suppressor, by IHC, technical only
Learn more
Rearrangements involving the IGH gene have been identified in about 50% of non-Hodgkin B-cell lymphomas (NHLs) and correlated to clinically relevant subgroups. A t(14;18)(q32;q21) is found in 88.1% of follicular…
Learn more
I BER EP4

BER-EP4

Carcinoma vs.mesothelioma; by IHC
Learn more
MALT lymphomas (also known as extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue) constitute about 8% of all non-Hodgkin lymphomas. The most common structural abnormality associated with MALT lymphomas…
Learn more
I HMB 45

HMB 45

Melanoma associated marker; by IHC
Learn more
I SOX11

SOX-11

SOX-11 Immunohistochemistry
Learn more
I FOXP3

FOX-P3

FOX-P3 Immunohistochemistry
Learn more
Deletions of chromosome 1p and 19q arms are frequent genetic abnormalities in primary human gliomas and are especially common in oligodendrogliomas. While 1p deletions are relatively common in other types…
Learn more
CD163 histiocytes, by IHC, technical only
Learn more
P57 Immunohistochemistry, technical only
Learn more
I CK20

CK 20

low molecular weight; by IHC
Learn more
Programmed death-1 immune response marker, technical only
Learn more
Human Epidermal Receptor Gastric; by IHC
Learn more
Pan B cell, follicular dendritic cells, technical only
Learn more
Translocations of chromosome 8 are common aberrations in the B-cell non-Hodgkin lymphoma group. The presence of the typical t(8;14) or the rare variants t(8;22) and t(2;8) has been confirmed in…
Learn more
T cell, NK cells; by IHC, technical only
Learn more
I CD117

c-kit, CD117

Myeloid, mast cell, GIST; by IHC
Learn more
I CK7

CK7 54kD

Low molecular weight; by IHC
Learn more
Cytokeratin 7/8, keratin, epithelial; by IHC
Learn more
Melanoma associated marker/Mart 1; by IHC
Learn more
I P63NU

p63 nuclear

Tumor suppressor gene protein; byIHC
Learn more
I DESMIN

Desmin

Desmin filament protein, Muscle; by IHC
Learn more
I CD45RO

CD45RO

CD45RO Immunohistochemistry
Learn more
I C-MYC

c-MYC

c-MYC Immunohistochemistry
Learn more
I MUC1

MUC1

MUC1 Immunohistochemistry
Learn more
I CD163

CD163

CD163 histiocytes, by IHC
Learn more
BL-CAM, integral membrane glycoprotein, Early B-cell, Hairy Cell leukemia [I CD22]
Learn more
CD42b glycoprotien, GPIb, megakaryocyte marker
Learn more
I CD42b

CD42b

CD42b glycoprotien, GPIb , megakaryocyte marker
Learn more
Stains the alpha subunit of interleukin-2 receptor on the membrane of activated T cells
Learn more
BL-CAM, Integral membrane glycoprotein, Early B-Cell, Hairy Cell Leukemia
Learn more
I CD25

CD25

Stains the alpha subunit of interleukin-2 receptor on the membrane of activated T cells
Learn more
Arginase 1 immunohistochemistry, technical only
Learn more
I CD1a

CD1a

T-cell / NK cell lymphoma; by IHC
Learn more
I CK8/18

CK 8/18

Lw molecular weight; by IHC
Learn more
I CD31

CD31

Endothelial cells; by IHC
Learn more
I INHIBIN*

Inhibin

Adrenal cortical, sex chord stromal; by IHC
Learn more
I CD56

CD56

T-cell / NK cell lymphoma; by IHC
Learn more
I CD43

CD43

T & B-cell subset, myeloid, histiocytes, Lymphoma; by IHC
Learn more
I CD23

CD23

Activated B-cells, B-cell lymphoma; by IHC
Learn more
I CD99

CD99

Ewings sarcoma, PNET , sarcoma, lymphoma; IHC
Learn more
I FASCIN*

Fascin

Hodgkin's lymphoma,Reed Sternberg cells; by IHC
Learn more
I CD15

CD15

Epithelial, myeloid, Reed-Sternberg cell; by IHC
Learn more
I CD30

CD30

Ki-1 activated T, B-cells, Reed-Sternberg cell; by IHC
Learn more
I BCL6

BCL6

Follicle center B-cell; by IHC
Learn more
I P53

P53

Tumor suppressor, prognostic; by IHC
Learn more
I BCL2

BCL2

Follicular lymphoma, apoptosis inhibiting protein; by IHC
Learn more
I CD20

CD20

Pan B-cell, B-cell lymphoma; by IHC
Learn more
Cytokeratin 7/8, keratin, epithelial; by IHC
Learn more
Gastro Intestinal Stromal Tumors; by IHC
Learn more
I PAX5

PAX-5

B-cell transription factor, B-cell lymphoma; by IHC
Learn more
I ARG1

Arginase-1

Arginase 1 Immunohistochemistry
Learn more
I NAPA

Napsin A

Napsin A Immunohistochemistry
Learn more
I GRANB

Granzyme B

Cytotoxic T cell subset, NK cell; by IHC
Learn more
I ECAD

E-cadherin

Ductal-type breast carcinoma, invasion; by IHC
Learn more
I CALRT

Calretinin

Carcinoma vs.mesothelioma; by IHC
Learn more

    Etiam magna arcu, ullamcorper ut pulvinar et, ornare sit amet ligula. Aliquam vitae bibendum lorem. Cras id dui lectus. Pellentesque nec felis tristique urna lacinia sollicitudin ac ac ex. Maecenas mattis faucibus condimentum. Curabitur imperdiet felis at est posuere bibendum. Sed quis nulla tellus.

    ADDRESS

    63739 street lorem ipsum City, Country

    PHONE

    +12 (0) 345 678 9

    EMAIL

    info@company.com